JD Vance urges Elon Musk to rejoin MAGA before midterms, highlighting Musk's political influence and past contributions to the Republican cause.
Novartis' drug ianalumab meets Phase III endpoints in Sjögren's disease trials, potentially offering the first targeted therapy for this chronic autoimmune disorder.
Micron boosts revenue and earnings outlook on strong AI and DRAM demand, reflecting robust market conditions for memory products.
JD Vance urges Elon Musk to rejoin MAGA before midterms, highlighting Musk's political influence and past contributions to the Republican cause.
Novartis' drug ianalumab meets Phase III endpoints in Sjögren's disease trials, potentially offering the first targeted therapy for this chronic autoimmune disorder.
Micron boosts revenue and earnings outlook on strong AI and DRAM demand, reflecting robust market conditions for memory products.